SCHEMBL20119122

SCHEMBL20119122

N#Cc1c(N)nn2ccc(N3CCC(O)C3)nc12

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SMPD3 Q9NY59 11/20 0.51
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ JAK2 O60674 4/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ PRKDC P78527 1/20 0.39
▸ CHUK O15111 1/20 0.39
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ AR P10275 1/20 0.37
▸ TYK2 P29597 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23865295 1.00 SMPD3 (0.51) SMPD3KDM4EALDH1A1GAAJAK2
SCHEMBL20119481 0.87 SMPD3 (0.43) SMPD3ALDH1A1GAAIRAK4
SCHEMBL21319640 0.86 SMPD3 (0.59) SMPD3ALDH1A1IRAK4
SCHEMBL20119489 0.82 SMPD3 (0.54) SMPD3JAK2JAK3PRKDCIRAK4
SCHEMBL21319573 0.80 SMPD3 (0.52) SMPD3JAK2JAK3PRKDCIRAK4
SCHEMBL21319519 0.80 SMPD3 (0.52) SMPD3JAK2JAK3PRKDCIRAK4
SCHEMBL21319518 0.74 SIGMAR1 (0.36) SMPD3KDM4EALDH1A1GAAIRAK4
SCHEMBL20119928 0.74 MAPT (0.45) SMPD3ALDH1A1IRAK4
SCHEMBL19560117 0.72 SMPD3 (0.62) SMPD3IRAK4
SCHEMBL21319568 0.71 SMPD3 (0.50) SMPD3JAK2JAK3IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3533796-A1 AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2019-09-04 — — EP disclosed
WO-2018077246-A1 AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR 正大天晴药业集团股份有限公司 2018-05-03 — — WO disclosed
Send feedback